[{"address1": "Dr. Neergaards Vej", "address2": "5th Floor", "city": "Horsholm", "zip": "2970", "country": "Denmark", "phone": "45 31 31 97 53", "website": "https://evaxion.ai", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based cancer vaccine that has completed Phase 1/2a trial to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers, including non-small cell lung cancer. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, a viral vaccine product candidate for targeting Cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.", "fullTimeEmployees": 46, "companyOfficers": [{"maxAge": 1, "name": "Mr. Andreas Holm Mattsson", "age": 49, "title": "Founder & Chief AI Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 326000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas Frederik Schmidt M.Sc.", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 77000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Birgitte  Rono Ph.D.", "age": 49, "title": "Chief Scientific Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 343000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Helen  Tayton-Martin", "age": 58, "title": "Chief Executive Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Benjamin Ole Wolthers", "title": "Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.77, "open": 4.81, "dayLow": 4.68, "dayHigh": 5.02, "regularMarketPreviousClose": 4.77, "regularMarketOpen": 4.81, "regularMarketDayLow": 4.68, "regularMarketDayHigh": 5.02, "payoutRatio": 0.0, "beta": 0.285, "forwardPE": -13.71858, "volume": 63814, "regularMarketVolume": 63814, "averageVolume": 338432, "averageVolume10days": 113640, "averageDailyVolume10Day": 113640, "bid": 4.3, "ask": 7.69, "bidSize": 2, "askSize": 2, "marketCap": 39282412, "fiftyTwoWeekLow": 1.2, "fiftyTwoWeekHigh": 12.15, "allTimeHigh": 1252.0, "allTimeLow": 1.2, "priceToSalesTrailing12Months": 5.134956, "fiftyDayAverage": 5.6298, "twoHundredDayAverage": 3.50011, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1487404160, "profitMargins": -0.70824, "floatShares": 212378673, "sharesOutstanding": 8340215, "sharesShort": 125539, "sharesShortPriorMonth": 127610, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0150999995, "heldPercentInsiders": 0.18386999, "heldPercentInstitutions": 0.053969998, "shortRatio": 1.23, "shortPercentOfFloat": 0.0185, "impliedSharesOutstanding": 8340215, "bookValue": 2.61, "priceToBook": 1.8045977, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -5418000, "trailingEps": -4.0, "forwardEps": -0.34333, "lastSplitFactor": "1:5", "lastSplitDate": 1736812800, "enterpriseToRevenue": 194.432, "enterpriseToEbitda": -168.102, "52WeekChange": 0.004210472, "SandP52WeekChange": 0.14561749, "quoteType": "EQUITY", "currentPrice": 4.71, "targetHighPrice": 19.75, "targetLowPrice": 10.0, "targetMeanPrice": 14.1875, "targetMedianPrice": 13.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 10572000, "totalCashPerShare": 0.033, "ebitda": -8848250, "totalDebt": 0, "totalRevenue": 7650000, "revenuePerShare": 1.648, "returnOnAssets": -0.25617, "returnOnEquity": -0.64991, "grossProfits": 7650000, "revenueGrowth": 1.483, "grossMargins": 1.0, "ebitdaMargins": -1.15663, "operatingMargins": 0.4035, "financialCurrency": "USD", "symbol": "EVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": -1.25786, "regularMarketPrice": 4.71, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "postMarketChangePercent": 0.8492561, "postMarketPrice": 4.75, "postMarketChange": 0.03999996, "regularMarketChange": -0.0599999, "regularMarketDayRange": "4.68 - 5.02", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 338432, "fiftyTwoWeekLowChange": 3.51, "fiftyTwoWeekLowChangePercent": 2.925, "fiftyTwoWeekRange": "1.2 - 12.15", "fiftyTwoWeekHighChange": -7.4399996, "fiftyTwoWeekHighChangePercent": -0.61234564, "fiftyTwoWeekChangePercent": 0.4210472, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "earningsCallTimestampStart": 1748349000, "earningsCallTimestampEnd": 1748349000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.0, "epsForward": -0.34333, "epsCurrentYear": -0.02, "priceEpsCurrentYear": -235.5, "shortName": "Evaxion A/S", "longName": "Evaxion A/S", "corporateActions": [], "postMarketTime": 1767394382, "regularMarketTime": 1767387600, "exchange": "NCM", "messageBoardId": "finmb_319014926", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.9197998, "fiftyDayAverageChangePercent": -0.16338055, "twoHundredDayAverageChange": 1.2098901, "twoHundredDayAverageChangePercent": 0.34567204, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "prevName": "Evaxion Biotech A/S", "nameChangeDate": "2026-01-02", "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2026-01-03"}]